Jesus M. Prieto Valtueña-rekin lankidetzan egindako argitalpenak (13)

2017

  1. Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularis

    Human Gene Therapy Clinical Development, Vol. 28, Núm. 2, pp. 68-73

  2. Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells

    Translational Research, Vol. 188, pp. 80-91.e2

2013

  1. Prognostic factors and prevention of radioembolization-induced liver disease

    Hepatology, Vol. 57, Núm. 3, pp. 1078-1087

2011

  1. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages

    Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971

2010

  1. Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma

    International Journal of Radiation Oncology Biology Physics, Vol. 77, Núm. 5, pp. 1441-1448

2009

  1. A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma

    Hepato-Gastroenterology, Vol. 56, Núm. 96, pp. 1683-1688

2006

  1. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma

    International Journal of Radiation Oncology Biology Physics, Vol. 66, Núm. 3, pp. 792-800

1997

  1. Partial splenic embolization in the treatment of thrombocytopenia after liver transplantation

    Transplantation, Vol. 63, Núm. 3, pp. 482-484

1994

  1. Transjugular intrahepatic portocaval shunt after thrombus disruption in partially thrombosed portal veins

    Cardiovascular and Interventional Radiology, Vol. 17, Núm. 2, pp. 106-109

  2. Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: A follow-up study

    CardioVascular and Interventional Radiology, Vol. 17, Núm. 1, pp. 7-11

1993

  1. Transjugular intrahepatic portosystemic shunt: Evaluation with Doppler sonography

    Radiology, Vol. 186, Núm. 2, pp. 529-534

1992

  1. Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis

    European Journal of Radiology, Vol. 15, Núm. 3, pp. 211-214

1991

  1. Hepatic vein involvement in hepatocellular carcinoma: Its disappearance with intra-arterial chemotherapy

    Regional Cancer Treatment, Vol. 4, Núm. 2, pp. 60-63